AI Visibility Scorecard
LUCEMYRA (lofexidine) | FDA Approved
lucemyra.com · Healthcare
Somewhat visible. AI bots can read LUCEMYRA (lofexidine) | FDA Approved, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 5 times
Meta AI · Claude
#306,366 of 923,585 in Healthcare for AI visibility
61
AI Naming Predictability
iLikely to be named · 61/100
5
AEO Visibility
iBorderline · 5.1/10
25
Muse Index Score
iAI agent readiness
Basic · 25/100
0
AI Adoption
iNone detected · 0/100
About LUCEMYRA (lofexidine) | FDA Approved
from our crawl and measurement
LUCEMYRA (lofexidine), based in Anaheim, CA, describes itself simply: "Discover Lucemyra.com - the official site for the only FDA-approved non-opioid treatment to ease opioid withdrawal symptoms in adults." To AI engines like ChatGPT and Perplexity it is partially visible, scoring 5.5 out of 10, readable in places, missing in others.
Under the hood there is structured data on the page (WebPage, BreadcrumbList, WebSite) and a sitemap and a readable heading structure, but the score is capped by what is missing: an llms.txt file.
AI crawlers have visited the site once in our tracking, so the engines are already looking.
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Fair
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Good
Clear headings and answer-style content.
Entity Clarity
Strong
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.1/10, LUCEMYRA (lofexidine) | FDA Approved has a working base to build on - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for LUCEMYRA (lofexidine) | FDA Approved
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for LUCEMYRA (lofexidine) | FDA Approved.
Source & Attribution
Scored by Engagemii on August 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/lucemyra
Cite this score: Engagemii (2026). "AEO Score for LUCEMYRA (lofexidine) | FDA Approved." Retrieved from https://engagemii.com/aeo/brands/lucemyra
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform